AI boosts polyp detection in colonoscopy: over 5,000 tested
NCT ID NCT05322993
First seen Jan 25, 2026 · Last updated Jun 23, 2026 · Updated 21 times
Summary
This completed study tested whether an AI system called GI Genius helps doctors spot polyps during colonoscopy. Over 5,000 adults participated. The goal was to see if AI improves detection rates and whether using AI has a lasting learning effect. Results could lead to better colon cancer screening.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLONIC POLYP are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Haraldsplass Deaconess Hospital
Bergen, Vestland, 5009, Norway
-
Haukeland University Hospital
Bergen, Vestland, 5021, Norway
-
Kanalspesialistene AS
Bergen, Vestland, 5068, Norway
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GI Genius artificial intelligence device
What this could lead to
If AI proves helpful, it could become a standard tool to improve colon cancer screening and reduce missed polyps.
What could go wrong
This trial is complete but only measures detection rates, not long-term health outcomes. AI may not reduce cancer risk or may cause unnecessary procedures.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.